REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Kamilla-Pharma Bt. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: KAMILLA-PHARMA Kereskedelmi es Szolgaltato Bt. Profile Updated: August 16, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Hungarian Download a sample report

Kamilla-Pharma Bt. is an enterprise based in Hungary. Its main office is in Ajak. The company operates in the Pharmacies and Drug Stores industry. The enterprise was incorporated on September 22, 1997. It currently has a total number of 4 (2023) employees. From the latest financial highlights, Kamilla-Pharma Bt. reported a net sales revenue increase of 11.45% in 2022. During that time, Kamilla-Pharma Bt.’s total assets grew by 8.37%. In 2022, Kamilla-Pharma Bt.’s net profit margin decreased by 0.34%.

Headquarters
Kiss Erno u. 5.
Ajak; Szabolcs-Szatmar-Bereg; Postal Code: 4524

Contact Details: Purchase the Kamilla-Pharma Bt. report to view the information.

Basic Information
Total Employees:
Purchase the Kamilla-Pharma Bt. report to view the information.
Outstanding Shares:
Purchase the Kamilla-Pharma Bt. report to view the information.
Registered Capital:
Purchase the Kamilla-Pharma Bt. report to view the information.
Incorporation Date:
September 22, 1997
Key Executives
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Kamilla-Pharma Bt. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
11.45%▲
Total operating revenue
11.96%▲
Operating profit (EBIT)
5.97%▲
EBITDA
5.82%▲
Net Profit (Loss) for the Period
6.01%▲
Total assets
8.37%▲
Total equity
-13.09%▼
Operating Profit Margin (ROS)
-0.38%▼
Net Profit Margin
-0.34%▼
Return on Equity (ROE)
5.43%▲
Quick Ratio
-1.34%▼
Cash Ratio
-1.21%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo